SOURCES:
American Academy of Bodily Medication and Rehabilitation: “PASC Dashboard.”
Janna Friedly, MD, govt director, Publish-COVID Rehabilitation and Restoration Clinic, College of Washington.
Nationwide Institutes of Well being: “Coronavirus Illness 2019 (COVID-19) Therapy Pointers,” “RECOVER: Researching COVID,” “RECOVER Program Takes First Steps in Advancing Towards Medical Trials to Higher Perceive Lengthy COVID.”
Most cancers: “Prevalence and Traits of Reasonable to Extreme Fatigue: A Multicenter Research in Most cancers Sufferers and Survivors.”
Nationwide Institute for Well being Care and Excellence: “Continual Fatigue Syndrome/Myalgic Encephalomyelitis (or Encephalopathy): Analysis and Administration.”
Monica Verduzco-Gutierrez, MD, chair of rehabilitation drugs, director, COVID-19 Restoration Clinic, College of Texas Well being Science Middle at San Antonio.
PM&R: “Multidisciplinary Collaborative Consensus Steerage Assertion on the Evaluation and Therapy of Fatigue in Postacute Sequelae of SARS-CoV-2 an infection (PASC) Sufferers.”
The Journal of Head Trauma Rehabilitation: “Effectiveness of Amantadine Hydrochloride within the Discount of Continual Traumatic Mind Damage Irritability and Aggression.”
CNS Medicine: “Modafinil: A Evaluation of its Pharmacology and Medical Efficacy within the Administration of Narcolepsy.”
Frontiers in Neurology: “Methylphenidate Therapy of Cognitive Dysfunction in Adults After Gentle to Reasonable Traumatic Mind Damage: Rationale, Efficacy, and Neural Mechanisms.”
PM&R: “Multi-Disciplinary Collaborative Consensus Steerage Assertion on the Evaluation and Therapy of Cognitive Signs in Sufferers With Publish-Acute Sequelae of SARS-CoV-2 An infection (PASC).”
Annals of Medical and Translational Neurology: “Persistent Neurologic Signs and Cognitive Dysfunction in Non-Hospitalized Covid-19 Lengthy Haulers.”
Alba Miranda Azola, MD, co-director, Publish-Acute COVID-19 Crew, Johns Hopkins College College of Medication, Baltimore.
U.S. Nationwide Library of Medication: “SARS-CoV-2 Viral Persistence Research (PASC) – Research of Lengthy COVID-19.”
PolyBio: “LongCovid Analysis Consortium.”
Gary H. Gibbons, MD, director, Nationwide Coronary heart, Lung, and Blood Institute.
Recent Comments